RxDoctor Payments Data

James Labelle

Pediatric Hematology-Oncology · Chicago, ILNPI 1700060472

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Vertex accounts for 80.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $42,065, more than ten times the $3,259 reported in 2019. Among pediatric hematology-oncology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,755in general payments, 2019–2025

Across 59 payments — averaging $1487.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$71K
  • Pfizer$7K
  • AbbVie$6K
  • Novartis$3K
  • Astellas Pharma US Inc$99
$408,309in research payments, 2019–2025

Across 18 payments — averaging $22,684 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$273K
  • AbbVie$135K
  • Gilead$520

What the payments were for

  • Consulting fees$48,52055%
  • Speaking & faculty fees$22,84526%
  • Travel & lodging$14,88917%
  • Food & beverage$1,4022%
  • Education$990%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex45$70,994
Pfizer6$7,434
AbbVie2$5,865
Novartis5$3,363
Astellas Pharma US Inc1$99

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,755 in reported general payments places this provider in the 90th percentile of 78 pediatric hematology-oncology providers in Illinois.

See all pediatric hematology-oncology providers in Illinois

Other pediatric hematology-oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →